Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-16

Clinical Trial Update: Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study of tirzepatide in women with obesity and endometrial intraepithelial neoplasia or Grade 1 endometrioid endometrial cancer. The trial is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tirzepatide (Mounjaro) (tirzepatide)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Endometrial Cancer, Endometrial Intraepithelial Neoplasia | Phase 2 | Status: NOT_YET_RECRUITING